Thursday, July 9, 2026

Patent directory · USPTO A61K / A61P

Patents matching “MiNK Therapeutics, Inc.”

4 pharma patents match "MiNK Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "MiNK Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “MiNK Therapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 12391741

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Aug 19, 2025 · Expires Aug 14, 2045

    granted
  2. US 11898165

    Engineered host cells and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  3. US 11718658

    T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  4. US 11613764

    T cell receptors that bind to NY-ESO-1 and methods of use thereof

    MiNK Therapeutics, Inc. · Granted Mar 28, 2023 · Expires Mar 23, 2043

    granted